Do meal replacement drinks have a role in diabetes management?

被引:8
|
作者
Ditschuneit, Herwig H. [1 ]
机构
[1] Univ Ulm Klinikum, Med Klin, DE-89081 Ulm, Germany
关键词
D O I
10.1159/000094450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The poor effectiveness of conventional dietary treatment for weight loss and weight maintenance in patients with type-2 diabetes may be improved by a meal replacement strategy that provides a strong structured meal plan with reasonable opportunity for dietary variety. Typical meal replacement programs fix the intake of one or two meals per day with a calorie-controlled, nutritionally balanced commercial formulation, and allow prudent additional meals and snacks. In obese subjects, diets with meal replacements have proven to be more efficient than conventional diets. Patients on the meal replacement regimen lost 7.3 and 8.4% of initial body weight after 12 weeks and 4 years, respectively, whereas the patients on the conventional diet had lost 1.4% and 3.2% of initial body weight after 12 weeks and 4 years, respectively. The meal replacement plan has also proven to be effective in patients with type-2 diabetes. After 6 and 12 months, patients in the meal replacement group achieved on average a weight loss of 5.24 and 4.35% of their initial body weight, respectively. In contrast, after 6 and 12 months, patients on the individualized diet plan achieved on average a weight loss of 2.85 and 2.36% of their initial body weight, respectively. Meal replacements offer a promising strategy for treating obese patients with type-2 diabetes. Copyright (c) 2006 Nestec Ltd.
引用
收藏
页码:171 / 181
页数:11
相关论文
共 50 条
  • [21] Does exercise have a role in the management of gestational diabetes mellitus?
    Groeller, Herbert
    Lowe, Sandra
    Worsley, Anthony
    Jenkins, Arthur
    OBSTETRIC MEDICINE, 2010, 3 (04) : 133 - 138
  • [22] Meal replacement A valuable tool for weight management
    Li, Zhaoping
    Zerlin, Alona
    Bowerman, Susan
    Heber, David
    AGRO FOOD INDUSTRY HI-TECH, 2009, 20 (05): : 51 - 54
  • [23] Clinical pharmacists in diabetes management: What do minority patients with uncontrolled diabetes have to say?
    Nabulsi, Nadia A.
    Yan, Connie H.
    Tilton, Jessica J.
    Gerber, Ben S.
    Sharp, Lisa K.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (05) : 708 - 715
  • [24] Do Corticosteroids Still Have a Role in the Management of Third Molar Surgery?
    Ngeow, Wei Cheong
    Lim, Daniel
    ADVANCES IN THERAPY, 2016, 33 (07) : 1105 - 1139
  • [25] Do butalbital-containing products have a role in the management of migraine?
    Wenzel, RG
    Sarvis, CA
    PHARMACOTHERAPY, 2002, 22 (08): : 1029 - 1035
  • [26] DO THE IMIDAZOLES HAVE A ROLE IN THE MANAGEMENT OF GENITOURINARY FUNGAL-INFECTIONS
    WISE, GJ
    GOLDBERG, PE
    KOZINN, PJ
    JOURNAL OF UROLOGY, 1985, 133 (01): : 61 - 64
  • [27] Do Corticosteroids Still Have a Role in the Management of Third Molar Surgery?
    Wei Cheong Ngeow
    Daniel Lim
    Advances in Therapy, 2016, 33 : 1105 - 1139
  • [28] Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
    Consoli, A.
    Formoso, G.
    DIABETES OBESITY & METABOLISM, 2013, 15 (11): : 967 - 977
  • [29] Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes?
    Costello, Rebecca B.
    Dwyer, Johanna T.
    Saldanha, Leila G.
    Bailey, Regan L.
    Wambogo, Edwina
    FASEB JOURNAL, 2016, 30
  • [30] Could glucagon antagonists have a role in the management of Type 1 diabetes?
    Panicker, J.
    Nair, S.
    Ahmed, S. H.
    Joseph, F.
    Ewins, D.
    DIABETIC MEDICINE, 2016, 33 : 17 - 17